Form 4: SelectQuote Director Chris Wolfe Acquires Restricted Stock Units

Director Chris Wolfe reports the acquisition of 28,508 restricted stock units in SelectQuote, Inc.

Summary

• On February 28, 2025, Chris Wolfe, a director of SelectQuote, Inc., acquired 28,508 restricted stock units (RSUs).
• These RSUs were granted under the company's 2020 Omnibus Incentive Plan.
• Each RSU represents the right to receive one share of SelectQuote's common stock.
• The RSUs vest ratably in three annual installments starting on the one-year anniversary of the grant date, contingent upon continued service on the Board of Directors.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a standard compensation practice that aligns director interests with shareholder value. There are no indications of negative events or concerns.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders, incentivizing continued service and contribution to the company's success.

Future Outlook

The vesting of the restricted stock units is contingent upon the recipient's continued service on the Company's Board of Directors.

Industry Context

Grants of restricted stock units to directors are a common practice to align their interests with those of the company and its shareholders, promoting long-term value creation.

Comparison to Industry Standards

• Equity compensation for board members is a standard practice across publicly traded companies.
• The size and vesting schedule of the RSU grant would need to be compared to similar companies in the insurance or technology sectors to determine if it is in line with industry norms.
• Companies like eHealth, Inc. and GoHealth, Inc. could be considered peers for comparison of executive and director compensation packages.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it incentivizes the director to remain engaged and contribute to the company's long-term success.

Key Dates